An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network

AIM: Fenofibrate, a PPAR-α inhibitor used for treating dyslipidemia, has well-documented anti-inflammatory effects that vary between individuals. While DNA sequence variation explains some of the observed variability in response, epigenetic patterns present another promising avenue of inquiry due to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacogenomics
Main Authors: Yusuf, Nabiha, Hidalgo, Bertha, Irvin, Marguerite R, Sha, Jin, Zhi, Degui, Tiwari, Hemant K, Absher, Devin, Arnett, Donna K, Aslibekyan, Stella W
Formato: Artigo
Idioma:Inglês
Publicado em: Future Medicine Ltd 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593083/
https://ncbi.nlm.nih.gov/pubmed/28835163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2017-0037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados